Brucella epitope recognition by CD8+T cells
Brucella epitope recognition by CD8+T cells
批准号:
8371098
负责人:
Jerome Scott Harms
金额:
$37.63万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-12-15 至 2017-04-30
关键词:
AcuteAffectAnimalsAntigensBacteriaBacterial InfectionsBrucellaBrucella VaccineBrucella abortusBrucella melitensisBrucellosisCD8B1 geneCell Cycle KineticsCell physiologyCellsChronicDataDevelopmentDiseaseEffectivenessEffector CellEpitopesEvaluationFailureFutureGenerationsGoalsHumanImmuneImmune responseImmunityIn VitroInbred BALB C MiceInfectionInterferonsInterleukin-2LinkMHC Class I GenesMemoryMusPathogenesisPeptidesPhenotypePlayPopulationPositioning AttributeProductionProteinsResolutionRoleShapesSurfaceT cell responseT memory cellT-LymphocyteTNF geneTransgenic MiceVaccine DesignVaccinesWorkZoonosesbasecell killingcell mediated immune responsecytokinecytotoxicexhaustexhaustionfunctional lossimprovedin vivokillingsmacrophagepathogenresponsetranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): CD8+T cells are significant because they clear intracellular infections; however, subverting these immune cells has implications to long-term infections. We will study how Brucella melitensis, a facultative intracellular bacterium, chronically persists in animals in the presence of an immune response. We hypothesize that low numbers and ineffectual CD8+T cells permit continuing infection. We have found BALB/c mice infected with B. melitensis results in chronic infection lasting >12 months using bioluminescent Brucella. Evaluation of the CD8+T cell memory pool from these mice reveals a failure to maintain the CD8+T cell memory phenotype (LFA1hi, KLRG1lo, and CD127hi), or polyfunctional cytokine expression (IL-2, IFN-? and TNF-?). These findings indicate CD8+T cells express an "exhausted" phenotype suggesting that Brucella evades this known effector mechanism for removing intracellular pathogens. Further, a Brucella protein, TcpB, can inhibit CD8+T cell killing of Brucella peptide expressing target cells in vivo. Our long-term goal is to understand how the bacteria remain in a chronic state in the presence of an immune response, by investigating the following Aims: Aim 1: To determine the CD8+T cell response in BALB/c mice during acute and chronic infection. We will compare the magnitude and effectiveness of CD8+Tcell responses in mice during acute and chronic infection using CD8+Teffector and memory markers, transcription factor expression, cytokine production, and in vivo killing. Impact: We will identify CD8+T cell phenotypic differences between acute and chronic infection and hypothesize an "exhausted" phenotype and ineffectual CD8+Tcells contribute to chronic brucellosis. Aim 2: To determine the protective capacity of Brucella-induced memory CD8+T cells. We will examine the capacity of adoptively transferred CD8+T cells from acute versus chronic infections to protect naive animals from a first infection. Impact: We expect CD8+Tcells from acute infected mice will protect naive mice better than cells from chronically infected mice supporting a loss of functional CD8+Tcells with chronic infection. Aim 3: To determine the inhibitory ability of Brucella TcpB on cytotoxic CD8+T cells. We will determine the ability of the TcpB protein to inhibit cytotoxic CD8+T cell killing of infected cells and the kinetics of this inhibition in vivo during infection. Impact: We expect that TcpB protein modulates the adaptive immune response by inhibiting CD8+T cell killing permitting long-term survival of Brucella-infected cells. Our studies represent a critical first step in elucidating how Brucella infection shapes CD8+T cell effector and memory responses. This work will fill a serious void in understanding the role of CD8+T cells in brucellosis that likely participate in the resolution of tis disease.
PUBLIC HEALTH RELEVANCE: Brucellosis is a chronic debilitating bacterial disease and a prevalent zoonosis worldwide. CD8+ T cells likely play a critical role in controlling the intracellular infection, but little is known regarding effector and memory responses of these CD8+T cells during infection. We will study how effector and memory CD8+T cells respond in acute versus chronic Brucella infection, and we hypothesize that these studies will identify a decline in functional CD8+T cells as brucellosis transitions from early to late infection. Our findings will provide future opportunities to enhance development and persistence of functional CD8+T cells leading to improved bacterial clearance and designing vaccines that can potentate CD8+T memory cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TIR domain containing protein from Brucella melitensis
-
批准号:8018517
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2010
-
负责人:Jerome Scott Harms
-
依托单位:
TIR domain containing protein from Brucella melitensis
-
批准号:7871109
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2010
-
负责人:Jerome Scott Harms
-
依托单位:
Brucella epitope recognition by CD8+T cells
-
批准号:8462526
-
项目类别:
-
资助金额:$35.37万
-
财政年份:2007
-
负责人:Jerome Scott Harms
-
依托单位:
Brucella epitope recognition by CD8+ T cells
-
批准号:7996602
-
项目类别:
-
资助金额:$36.02万
-
财政年份:2007
-
负责人:Jerome Scott Harms
-
依托单位:
Brucella epitope recognition by CD8+ T cells
-
批准号:7742653
-
项目类别:
-
资助金额:$36.38万
-
财政年份:2007
-
负责人:Jerome Scott Harms
-
依托单位:
Brucella epitope recognition by CD8+T cells
-
批准号:8837555
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2007
-
负责人:Jerome Scott Harms
-
依托单位:
海外基金